| VHLS | von Hippel–Lindau Syndrome |
| CCRC | Clear Cell Renal Carcinoma |
| MLPA | Multiplex Ligation-dependent Probe Amplification |
| NCCN | National Comprehensive Cancer Network |
| ACMG | American College of Medical Genetics |
| ASCO | American Society of Clinical Oncology |
| FFPE | Formalin-Fixed Paraffin-Embedded |
| HGVS | Human Genome Variation Society |
| COSMIC | Catalogue Of Somatic Mutations In Cancer |
| MEN2A | Multiple Endocrine Neoplasia type 2A |
| DNA | Deoxyribonucleic Acid |
| IGV | Integrative Genomic Viewer |
| CNS | Central Nervous System |
| NGS | Next-Generation Sequencing |
| CNV | Copy Number Variation |
| MAF | Minor Allele Frequency |
| VUS | Variant of Uncertain Significance |
| PCR | Polymerase Chain Reaction |
| PCR-RFLP | Polymerase Chain Reaction–Restriction Fragment Length Polymorphism |
| AMP | Association for Molecular Pathology |
| USA | United States of America |
| FDA | Food and Drug Administration |
| CAP | College of American Pathologists |
| HIF | Hypoxia-Inducible Factor |
| WGS | Whole-Genome Sequencing |
| WHO | World Health Organization |
| MRI | Magnetic Resonance Imaging |